期刊文献+

小鼠PARP1基因RNAi表达载体对Lewis细胞株的影响 被引量:1

下载PDF
导出
摘要 目的观察PARP-1基因RNAi表达载体对Lewis肺癌细胞的抑制及凋亡情况。方法以脂质体Lipofectimine?2000介导,将PARP-1-1308的siRNA表达载体转染Lewis肺癌细胞株,将其分为空白对照组、错义序列组、siRNA组,2Gy照射组、2Gy照射+错义序列组、2Gy照射+siR-NA组。应用MTT法检测转染细胞抑制率、流式细胞术分析转染siRNA后细胞的凋亡,并应用RT-PCR检测转染细胞Parp1mRNA表达水平。结果siRNA转染组及2Gy照射组的吸光度值与空白对照组比较差异有显著意义;2Gy照射组+siRNA组的吸光度值与2Gy照射组、siRNA组比较差异有显著意义。错义序列组与正常对照组比较无显著差异;2Gy照射组+错义序列组与2Gy照射组比较无显著差异。2Gy照射组+siRNA组对Lewis肺癌细胞的抑制率最高。RT-PCR检测结果显示转染细胞Parp1mRNA表达水平降低。siRNA转染、2Gy照射可诱导Lewis肺癌细胞凋亡,与正常对照组比较差异显著(P<0.05),并且siRNA转染可增加2Gy照射引起的Lewis肺癌细胞凋亡。结论针对PARP-1的RNAi可以提高Lewis肺癌细胞的抑制率及放疗引起的肿瘤细胞的凋亡。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2009年第8期969-970,共2页 Chinese Journal of Gerontology
  • 相关文献

参考文献11

  • 1Rouleau M,Aubin RA,Poirier GG.Poly(ADPribosyl)ated chromatin domains:access granted[J].J Cell Sci,2004;117:815-25.
  • 2Haince JF,Rouleau M,Hendzel MJ,et al.Targeting poly(ADP-ribosyl)ation:a promising approach in cancer therapy[J].Trends Mol Med,2005;11:456-63.
  • 3Farmer H,McCabe N,Lord CJ,et al.Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy[J].Nature,2005;434:917-21.
  • 4Bryant HE,Schultz N,Thomas HD,et al.Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase[J].Nature,2005;434:913-7.
  • 5王铁君,韩成敏,李星花,尹金植,陈玉丙,王红勇,李英普.小鼠PARP-1基因RNAi表达质粒的构建与筛选[J].中国生物制品学杂志,2009,22(2):143-146. 被引量:1
  • 6Beneke S,Bürkle A.Poly(ADP-Ribosyl)ation,PARP,and aging[J].Sci Aging Knowl Environ,2004;2004:159-62.
  • 7Affar EB,Dallaire AK,Castonguay V,et al.Role of poly(ADP-ribose) polymerase in rapid intracellular acidification induced by alkylating DNA damage[J].Proc Natl Acad Sci USA,2002;99:245-50.
  • 8Kapadia SB,Brideau-Andersen A,Chisari FV.Interference of hepatitis C virus RNA replication by short interfering RNAs[J].Proc Natl Acad Sci USA,2003;100:2014-8.
  • 9Qin XF,An DS,Chen IS,et al.Inhibiting HIV-l infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5[J].Proc Natl Acad Sci USA,2003;100:183-8.
  • 10Ying C,De CE,Neyts J.Selective inhibition of hepatitis B virus replication by RNA interference[J].Biochem Biophys Res Commun,2003;309:482-4.

二级参考文献12

  • 1Rouleau M, Aubin RA Poirier GG. Poly (ADP-ribosyl)ated chromatin domains: access granted. J Cell Sci, 2004, 117(Pt6): 815-825.
  • 2Hainee JF, Rouleau M, Hendzel MJ, et al. Targeting poly(ADP- ribosyl)ation: a promising approach in cancer therapy. Trends Mol Med, 2005, 11( 10): 456-463.
  • 3Farmer H, McCabe N, Lord CJ, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature, 2005, 434 (7035): 917-921.
  • 4Bryant HE, Schuhz N, Thomas HD, et al. Specific killing of BRCA2-defieient turnouts with inhibitors of poly (ADP-ribose) polymerase. Nature, 2005, 434(7035): 913-917.
  • 5Tong WM, Cortes U, Hande MP, et al. Synergistic role of Ku80 and poly (ADP-ribose) polymerase in suppressing chromosomal aberrations and liver cancer formation. Cancer Res, 2002, 62 (23): 6990-6996.
  • 6Audebert M, Salles B, Calsou P. Involvement of poly(ADP-ribose) polymerase-1 and XRCCI/DNA ligase III in an ahernative route for DNA double-strand breaks rejoining. J Biol Chem, 2004, 279 (53): 55117-55126.
  • 7Veuger SJ, Curtin NJ, Richardson C J, et al. Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly (ADPribose) polymerase- 1. Cancer Res, 2003, 63( 18 ): 6008-6015.
  • 8Brock WA, Mitas L, Bergh S, et al. Radiosensitization of human and rodent cell lines by INO-1001, a novel inhibitor of poly(ADP- ribose ) polymerase. Cancer Lett, 2004, 205 ( 2 ): 155-160.
  • 9Vanitharani R,Chellappan P,Fauquet CM. Short interfering RNA- mediated interference of gene expression an d viral DNA accumulation in cultured plant cells.Proc Natl Acad Sci USA, 2003, 100(16): 9632-9636.
  • 10Vargason J, Szittya G, Burgyan J, et al. Size selective recognition of siRNA by an RNA silencing suppressor. Cell, 2003, 115 (7): 799-811.

同被引文献17

  • 1Ghosh U, Bhattacharyya N P. Induction of apoptosis by the inhibitors of poly (ADP-ribose) polymerase in HeLa cells[J]. Mol Cell Biochem, 2009, 320(1-2) :15-23.
  • 2Figueroa J D, Malats N, Real F X, et al. Genetic variation in the base excision repair pathway and bladder cancer dsk[J]. Hum Genet, 2007, 121(2) :233-242.
  • 3Cimmino G, Pepe S, Laus G, et al. Poly(ADPR)polymerase-1 signalling of the DNA damage induced by DNA topoisomerase I poison in D54p53wt and U251p53mut glioblastoma cell lines[J]. Pharmacol Res, 2007, 55 (1) :49-56.
  • 4Ratnam K, Low J A. Current development of clinical inhibitors of poly (ADP-ribose) polymerase in oncology [J]. Clin Cancer Res, 2007, 13(5) :1383-1388.
  • 5Farmer H, McCabe N, Lord C J, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy [ J ]. Nature, 2005, 434 (7035) : 917 -921.
  • 6Fong P C, Boss D S, Yap T A, et al. Inhibition of poly (ADP-ribose) polymerase in tumors from BRCA mutation carriers[J]. N Engl J Med, 2009, 361 (2) :123- 134.
  • 7Nguewa P A, Fuertes M A, Cepeda V, et al. Poly (ADP-ribose) polymerase-1 inhibitor 3-aminobenzamide enhances apoptosis induction by platinum complexes in cisplatin-resistant tumor cells [ J ]. Med Chem, 2006, 2 ( 1 ) :47-53.
  • 8Calabrese C R, Almassy R, Barton S, et al. Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361[J ]. J Nail Cancer Inst, 2004, 96(1) :56-67.
  • 9Dykxhoorn D M, Palliser D, LiebermanJ. The silent treatment: siRNAs as small molecule drugs [ J ]. Gene Therapy, 2006,13 (6) :541-552.
  • 10Rouzier R, Bergzoll C, Brun J L, et al. The role of lymph node resection in ovarian cancer: analysis of the Surveillance, Epidemiology, and End Results (SEER) database[J]. BJOG, 2010, 117(12) :1451-1458.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部